Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Key facts
- Who runs it
- Dr. med. Marcus Herdener
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 120 people, planned
- Started
- 5 Feb 2024
- Planned end
- Mar 2026
- Type of study
- Interventional, 4 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Ketamine
- Placebo
- real-time fMRI neurofeedback training
- sham real-time fMRI neurofeedback training
- Record updated
- 20 December 2024
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 31 criteriaShow less
Who can take part
- Informed Consent as documented by signature
- Male and female cocaine users 18 to 55 years of age
- diagnostic and statisical manual (DSM)-5 diagnosis of CUD
- Willingness to comply with the study protocol as explained by investigator
- Normal level of language comprehension (German or Swiss-German)
Who cannot take part
- Previous suicide attempts during the last 2 years
- Medication directly affecting glutamate signaling (e. g. anticonvulsant medication)
- Any unstable psychoactive medication (no changes in compounds within last 4 weeks before start of study)
- Allergy, hypersensitivity, or other adverse reaction to previous use of ketamine
- Concurrent participation in other clinical study
- Current or lifetime psychotic disorders
- History of severe substance-induced psychosis
- Current or lifetime bipolar I or II disorders
- Current severe alcohol use disorder
- Current severe cannabis use disorder
- Current moderate or severe stimulant use disorder (other than cocaine)
- Current moderate or severe benzodiazepine use disorder
- Current opioid use disorder
- First-degree relatives with psychotic disorders
- Unmedicated or unstable hypertension
- Severe illness (e. g. myocardial ischemia or arrythmias, severe pulmonary secretions, glaucoma, congestive heart failure or angina, significant renal or hepatic impairment)
- Acute infection (e. g. pulmonary or upper respiratory tract infection)
- Severe central nervous system related traumas or disorders (e. g. stroke, cerebral trauma with loss of consciousness over more than 24h, epilepsy)
- Current suicidality
- Beck Depression Inventory Score greater than 25
- Insufficient treated or uncorrected hyperthyroidism
- Increased intracranial pressure
- Pregnancy or lactation
- Women of childbearing potential with no use of medically accepted contraceptive (e. g; condoms, contraceptive diaphragm, birth control pill, hormone injection, intrauterine device)
- BMI>35
- Contradictions to magnetic resonance imaging
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
This trial is currently available in Switzerland.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn about the effects of the combination of ketamine and realtime functional magnetic resonance imaging (fMRI) neurofeedback training in individuals with cocaine use disorder. The main questions the investigators aim to answer are:
Read full original descriptionShow less
* Can the investigators observe a positive, significant effect on percentage of cocaine use days of both interventions combined as well as stand alone interventions? * Is there a significant transfer effect of the neurofeedback training? * Is there a significant, ketamine-dependent change in glutamate levels in the nucleus accumbens?
Participants will be given ketamine and a realtime fMRI neurofeedback training. Both interventions are placebo-controlled. The investigators will compare the four intervention groups to investigate the effects of the stand-alone effects of the intervention and the combination of it.
The 4 groups in the trial
- rt-fMRI NFT / PlaceboTreatment being tested
Participants get real time neurofeedback based on an experimental regions' activity and receive a 0.9% saline solution (i.v.) over 40 minutes.
Treatment: Placebo and real-time fMRI neurofeedback training
- rt-fMRI NFT / KetamineTreatment being tested
Participants get real time neurofeedback based on an experimental regions' activity and receive 0.71mg ketamine (i.v.) per kilogram bodyweight.
Treatment: Ketamine and real-time fMRI neurofeedback training
- sham NFT / PlaceboPlacebo, for comparison
Participants get a real time neurofeedback based on a control regions' activity, which serves as a sham region and receive a 0.9% saline solution (i.v.) over 40 minutes.
Treatment: Placebo and sham real-time fMRI neurofeedback training
- sham NFT / KetamineTreatment being tested
Participants get a real time neurofeedback based on a control regions' activity, which serves as a sham region and receive 0.71mg ketamine (i.v.) per kilogram bodyweight.
Treatment: Ketamine and sham real-time fMRI neurofeedback training
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Boosting and Guiding Neuroplasticity by Combining Ketamine with Neurofeedback-assisted Learning - Towards an Individualized and Integrated Pharmaco-psychotherapy for Cocaine Addiction
- Criteria questions
- Built from NCT06125054, who can take part
- Publications
- Record updated
- 20 December 2024